Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Youlong Ma"'
Autor:
Minkyung Kim, Youlong Ma, Charudharshini Srinivasan, Thomas O’Connor, Srivalli N. Telikepalli, Dean C. Ripple, Scott Lute, Ashwinkumar Bhirde
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-13 (2023)
Abstract Subvisible particles (SVPs) are a critical quality attribute of injectable therapeutic proteins (TPs) that needs to be controlled due to potential risks associated with drug product quality. The current compendial methods routinely used to a
Externí odkaz:
https://doaj.org/article/59fedfcc14744d30b6b9e3712346a229
Publikováno v:
Microscopy and Microanalysis. 28:1444-1446
Autor:
Charudharshini Srinivasan, Christopher Calderon, Youlong Ma, Dean Ripple, Muhammad Ashraf, Thomas O'Connor
Publikováno v:
Microscopy and Microanalysis. 28:3150-3152
Autor:
Christopher P. Calderon, Dean C. Ripple, Charudharshini Srinivasan, Youlong Ma, Michael J. Carrier, Theodore W. Randolph, Thomas F. O’Connor
Publikováno v:
Pharmaceutical Research. 39:263-279
Publikováno v:
2022 7th International Conference on Power and Renewable Energy (ICPRE).
Autor:
Christopher P, Calderon, Dean C, Ripple, Charudharshini, Srinivasan, Youlong, Ma, Michael J, Carrier, Theodore W, Randolph, Thomas F, O'Connor
Publikováno v:
Pharmaceutical research. 39(2)
Digital microscopy is used to monitor particulates such as protein aggregates within biopharmaceutical products. The images that result encode a wealth of information that is underutilized in pharmaceutical process monitoring. For example, images of
Publikováno v:
Microscopy and Microanalysis. 26:2248-2250
Publikováno v:
Microscopy and Microanalysis. 27:90-91
Autor:
Yangping Liu, Sau Larry Lee, Leanna Hengst, Shiril Sivan, Maxwell Korang-Yeboah, Charudharshini Srinivasan, Yifan Wang, Celia N. Cruz, Christopher R. Beekman, Bandaranayake M. B. Bandaranayake, David D. Simon, Youlong Ma, Roxana Toth, Xiaofei Liu, Jason D. Rodriguez, Adil Mohammad
Publikováno v:
International journal of pharmaceutics. 568
Pharmaceutical containers for parenterals have been predominantly manufactured using glass as a packaging material of choice, especially Type-I glass, since it has been regarded as a chemically inert and an effective container closure system (CCS). N
Publikováno v:
International Journal of Pharmaceutics. 596:120248
Chemical incompatibility of the formulation with glass container can adversely impact the quality of parenteral products. The objective of this study is to investigate formulation-glass interactions at the inner surface of the glass containers that l